Author

Chunru Shi

Institutions: Guangdong Pharmaceutical University, State Administration of Traditional Chinese Medicine of the People's Republic of China, Chinese PLA General Hospital, State Key Laboratory of Kidney Diseases

Observed institutions: Sun Yat-sen University, Guangdong Pharmaceutical University, State Administration of Traditional Chinese Medicine of the People's Republic of China, Chinese PLA General Hospital, Chinese People's Liberation Army, State Key Laboratory of Kidney Diseases

ORCID: 0009-0000-1404-8521

Observed ORCID: 0009-0000-1404-8521

OpenAlex ID: A5069177782

Fufang Shenhua tablet inhibits renal fibrosis by inhibiting PI3K/AKT

2023 · Run Li, Chunru Shi, et al. · Phytomedicine · 78

Direct pharmacological targeting of Piezo1 by Paeoniflorin: a novel therapeutic approach for renal fibrosis

2025 · Run Li, Jikai Xia, et al. · Journal of Advanced Research · 29

The mechanisms underlying Chinese medicines to treat inflammation in diabetic kidney disease

2024 · Lingchen Deng, Chunru Shi, et al. · Journal of Ethnopharmacology · 26

Fufang shenhua tablet, astragali radix and its active component astragaloside IV: Research progress on anti-inflammatory and immunomodulatory mechanisms in the kidney

2023 · Run Li, Chunru Shi, et al. · Frontiers in Pharmacology · 25

Oleanolic acid and its analogues: promising therapeutics for kidney disease

2024 · Dan Pan, Yilun Qu, et al. · Chinese Medicine · 23

New findings in preventing recurrence and improving renal function in AHUS patients after renal transplantation treated with eculizumab: a systemic review and meta-analyses

2023 · Zheng Chun Tang, Huang Hui, et al. · Renal Failure · 11

Oleanolic acid inhibits mesangial cell proliferation and inflammatory response in mesangial proliferative glomerulonephritis through IL-17/ERK/AKT pathway

2025 · Dan Pan, Jikai Xia, et al. · International Immunopharmacology · 9

Paeoniflorin Attenuates the Progression of Diabetic Kidney Disease by Regulating Macrophage Differentiation

2025 · Chunru Shi, Run Li, et al. · Phytotherapy Research · 5

Direct pharmacological targeting of RAC1 by chlorogenic acid: A novel therapeutic approach for mesangial proliferative glomerulonephritis

2026 · Yilun Qu, Lingling Wu, et al. · Acta Pharmaceutica Sinica B

Works count: 9

Citation count: 206

H-index: 7

I10-index: 6